The price of Trelegy Ellipta varies depending on factors such as insurance coverage, pharmacy, and geographic location. A single inhaler can cost several hundred dollars without insurance.
What are Trelegy Ellipta's options for reducing out-of-pocket costs?
Patients may find ways to lower their Trelegy Ellipta costs through manufacturer discount programs, savings cards, or patient assistance programs, especially if they have commercial insurance. These programs often have eligibility requirements [1].
How does insurance affect the cost of Trelegy Ellipta?
Insurance plans, including Medicare and Medicaid, can significantly impact the final price of Trelegy Ellipta. The formulary status of the medication within a specific plan determines the co-payment amount. Some plans may require prior authorization or step therapy before covering Trelegy Ellipta [1].
Are there generic alternatives to Trelegy Ellipta?
As of late 2023, there are no generic versions of Trelegy Ellipta available. Trelegy Ellipta is a combination inhaler containing fluticasone furoate, umeclidinium, and vilanterol, and developing a generic equivalent requires navigating patent protections and bioequivalence studies [2].
When does Trelegy Ellipta's patent protection expire?
The patent landscape for Trelegy Ellipta is complex, involving multiple patents covering the drug itself and its delivery device. DrugPatentWatch.com tracks these patents, and while specific expiry dates can be intricate and subject to litigation, major patents for such combination therapies often extend for many years [3].
What is Trelegy Ellipta used for?
Trelegy Ellipta is a once-daily single-inhaler triple therapy used for the maintenance treatment of patients with COPD, including chronic bronchitis and/or emphysema, and for the treatment of asthma [1].
---
1. Trelegy Ellipta Official Website.
2. U.S. Food & Drug Administration (FDA) Orange Book.
3. DrugPatentWatch.com.